One-week triple therapy for Helicobacter pylori revealed, during these last few years, a decrease in the eradication rate, so that the prolongation of its duration has been proposed. A sequential scheme recently showed very satisfactory results. We performed a prospective randomised study with the aim of either evaluating whether the triple therapy prolongation may improve its effectiveness and comparing its outcome with that of sequential regimen.

The prolongation of triple therapy for Helicobacter pylori does not allow reaching therapeutic outcome of sequential scheme: a prospective, randomised study

Hassan, Cesare;
2004-01-01

Abstract

One-week triple therapy for Helicobacter pylori revealed, during these last few years, a decrease in the eradication rate, so that the prolongation of its duration has been proposed. A sequential scheme recently showed very satisfactory results. We performed a prospective randomised study with the aim of either evaluating whether the triple therapy prolongation may improve its effectiveness and comparing its outcome with that of sequential regimen.
2004
2-Pyridinylmethylsulfinylbenzimidazoles
Amoxicillin
Anti-Bacterial Agents
Anti-Ulcer Agents
Antitrichomonal Agents
Benzimidazoles
Clarithromycin
Dose-Response Relationship
Drug
Drug Administration Schedule
Drug Therapy
Combination
Dyspepsia
Female
Helicobacter Infections
Helicobacter pylori
Humans
Male
Middle Aged
Multivariate Analysis
Omeprazole
Patient Compliance
Peptic Ulcer
Prospective Studies
Smoking
Tinidazole
Treatment Outcome
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11699/75523
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? ND
social impact